StockClub

HNSBF

HNSBFHansa Biopharma AB$ --
Hansa Biopharma AB

Hansa Biopharma AB

HNSBF

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2025FY2025 Q4
Revenue
76M SEK
YoY +135.0%
Operating Income
-125M SEK
YoY +13.0%
Net Income
-165M SEK
YoY +40.3%
EPS
-1.62SEK
YoY +60.3%

Revenue

SEK222.1M
FY2024 Q1SEK56M
SEK56M
Q1
FY2024 Q2SEK90.3M
SEK90.3M
Q2
FY2024 Q3SEK139M
SEK139M
Q3
FY2024 Q4SEK171.3M
SEK171.3M
Q4
FY2025 Q1SEK66.3M
SEK66.3M
Q1
FY2025 Q2SEK115.5M
SEK115.5M
Q2
FY2025 Q3SEK146.1M
SEK146.1M
Q3
FY2025 Q4SEK222.1M
SEK222.1M
Q4
Actual
+SEK50.7M (+29.6%)

Net Income

SEK-528M
FY2024 Q1SEK-218.6M
SEK-218.6M
Q1
FY2024 Q2SEK-426.5M
SEK-426.5M
Q2
FY2024 Q3SEK-530.3M
SEK-530.3M
Q3
FY2024 Q4SEK-806.7M
SEK-806.7M
Q4
FY2025 Q1SEK-37.1M
SEK-37.1M
Q1
FY2025 Q2SEK-216M
SEK-216M
Q2
FY2025 Q3SEK-363M
SEK-363M
Q3
FY2025 Q4SEK-528M
SEK-528M
Q4
Actual
+SEK278.7M (+34.6%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020MISS
Actual:SEK6.1M
Est:SEK22.7M
FY2020MISS
SEK6.1M
FY2021BEAT
Actual:SEK33.9M
Est:SEK31.8M
FY2021BEAT
SEK33.9M
FY2022BEAT
Actual:SEK154.5M
Est:SEK125.1M
FY2022BEAT
SEK154.5M
FY2023MISS
Actual:SEK134.1M
Est:SEK134.3M
FY2023MISS
SEK134.1M
FY2024MISS
Actual:SEK171.3M
Est:SEK198.9M
FY2024MISS
SEK171.3M
FY2025BEAT
Actual:SEK222.3M
Est:SEK203.5M
FY2025BEAT
SEK222.3M

Analyst Estimates